We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 123

Pfizer v Ranbaxy; 55.2 proceeding; October 5, 2007 - atorvastatin

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 25 2007

The trial judge granted prohibition in respect of one patent claiming a novel crystalline form of atorvastatin (the "crystalline form patent") and denied prohibition in respect of another patent claiming a novel process for making atorvastatin (the "process patent"

Solvay v Apotex; 55.2 proceeding; March 6, 2008; pantoprazole, application for prohibition dismissed

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 21 2008

The Court dismissed the application on the basis that Altana had not proven that the allegation of non-infringement was not justified

Astrazeneca v. Apotex, interlocutory motion to strike affidavit in PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes refusing to strike an affidavit from the record

Sanofi-Aventis v. Laboratoire Riva; interlocutory motion on 55.2 proceeding; December 14, 2007 - Ramipril

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 17 2008

After cross-examinations had taken place, and approximately one week before the application record of Sanofi-Aventis was due, Riva brought a motion for leave to file further evidence

AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing

Lundbeck v. Cobalt, Genpharm and Apotex

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 7 2009

The Court granted prohibition in respect of each of the proceedings against each defendant

Canada (Attorney General) v. Celgene Corporation, appeal of a PMPRB decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 20 2010

The Court of Appeal overturned the decision of the Trial Judge and restored the decision of the PMPRB providing jurisdiction to the PMPRB over medicines imported under the Special Access Program

Recent cases

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • August 21 2009

The Court granted an order of prohibition to Purdue in the face of Pharmascience’s allegations that the patent was invalid

Abbott Laboratories Limited et al. v. The Minister of Health et al

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 20 2007

In this decision, the Court again dismissed a motion by an innovator to reverse the order of evidence in a 55.2 proceeding

Altana Pharma v Novopharm

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 16 2007

The Federal Court found that each side is limited to five experts in a case, subject to requesting leave of the Court to vary that number